11/14
05:32 pm
rvph
Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
Medium
Report
Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
11/14
05:25 pm
rvph
Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Medium
Report
Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights
11/12
08:00 am
rvph
Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia
High
Report
Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia
11/6
08:00 am
rvph
Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024
Low
Report
Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024
10/31
08:00 am
rvph
Reviva to Participate in the UBS Global Healthcare Conference
Neutral
Report
Reviva to Participate in the UBS Global Healthcare Conference
10/8
08:00 am
rvph
Reviva to Participate in the 2024 Maxim Healthcare Virtual Summit
Medium
Report
Reviva to Participate in the 2024 Maxim Healthcare Virtual Summit
10/2
08:30 am
rvph
Reviva to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
Medium
Report
Reviva to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
9/26
08:30 am
rvph
Reviva Pharmaceuticals to Participate in the Lytham Partners Fall 2024 Investor Conference
Medium
Report
Reviva Pharmaceuticals to Participate in the Lytham Partners Fall 2024 Investor Conference
11/14/2024
05:15 pm
RVPH
reviva pharmaceuticals holdings, inc.
MISS
Report
-5.5%
reviva pharmaceuticals holdings, inc.
8/14/2024
08:00 am
RVPH
reviva pharmaceuticals holdings, inc.
BEAT
Report
-1.6%
reviva pharmaceuticals holdings, inc.
11/14
05:26 pm
rvph
Form 8-K REVIVA PHARMACEUTICALS For: Nov 14
Medium
Report
Form 8-K REVIVA PHARMACEUTICALS For: Nov 14
11/14
05:17 pm
rvph
Form SC 13G/A REVIVA PHARMACEUTICALS Filed by: ARMISTICE CAPITAL, LLC
Medium
Report
Form SC 13G/A REVIVA PHARMACEUTICALS Filed by: ARMISTICE CAPITAL, LLC
11/14
05:16 pm
rvph
Form 10-Q REVIVA PHARMACEUTICALS For: Sep 30
Medium
Report
Form 10-Q REVIVA PHARMACEUTICALS For: Sep 30
11/14
04:17 pm
rvph
Form SC 13G REVIVA PHARMACEUTICALS Filed by: Schonfeld Strategic Advisors LLC
Medium
Report
Form SC 13G REVIVA PHARMACEUTICALS Filed by: Schonfeld Strategic Advisors LLC
11/12
09:27 am
rvph
Form 8-K REVIVA PHARMACEUTICALS For: Nov 12
High
Report
Form 8-K REVIVA PHARMACEUTICALS For: Nov 12
10/28
04:19 pm
rvph
Form ARS REVIVA PHARMACEUTICALS For: Dec 31
Low
Report
Form ARS REVIVA PHARMACEUTICALS For: Dec 31
10/28
04:17 pm
rvph
Form DEF 14A REVIVA PHARMACEUTICALS For: Dec 10
Low
Report
Form DEF 14A REVIVA PHARMACEUTICALS For: Dec 10
10/17
04:32 pm
rvph
Form PRE 14A REVIVA PHARMACEUTICALS For: Dec 10
High
Report
Form PRE 14A REVIVA PHARMACEUTICALS For: Dec 10
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register